Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Jen Chen

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
Journal of Medicinal Chemistry|April 18, 2003
Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agentsWen-Tai Li, Der-Ren Hwang, Ching-Ping Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 StudyNai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
The Journal of Biological Chemistry|November 14, 2014
A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2αShu-jen Chen, Nicholas E Hoffman, Santhanam Shanmughapriya, et al.
Nucleic Acids Research|October 30, 2014
A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cellsKuo-Feng Weng, Chuan-Tien Hung, Po-Ting Hsieh, et al.
Targeted Oncology|June 14, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis InhibitorsJoan R E Choo, Yi-Hua Jan, Samuel G W Ow, et al.
Journal of Medicinal Chemistry|August 4, 2006
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitorSyaulan Yang, Shu-Jen Chen, Min-Feng Hsu, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
Journal of Medicinal Chemistry|April 18, 2003
Synthesis and biological evaluation of N-heterocyclic indolyl glyoxylamides as orally active anticancer agentsWen-Tai Li, Der-Ren Hwang, Ching-Ping Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 StudyNai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
The Journal of Biological Chemistry|November 14, 2014
A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1/2αShu-jen Chen, Nicholas E Hoffman, Santhanam Shanmughapriya, et al.
Nucleic Acids Research|October 30, 2014
A cytoplasmic RNA virus generates functional viral small RNAs and regulates viral IRES activity in mammalian cellsKuo-Feng Weng, Chuan-Tien Hung, Po-Ting Hsieh, et al.
Targeted Oncology|June 14, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis InhibitorsJoan R E Choo, Yi-Hua Jan, Samuel G W Ow, et al.
Journal of Medicinal Chemistry|August 4, 2006
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitorSyaulan Yang, Shu-Jen Chen, Min-Feng Hsu, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.
Pageof 16